EUVIMEDEUVIMED entdecken
Crossref

Overexpression of SerpinB9 in non-seminomatous germ cell tumors

Toshiki Anami, Yuki Ibe, Lianbo Li, Yoshihiro Komohara, Hiroki Hirao, Mamoru Harada, Hiromu Yano, Yukio Fujiwara, Takanobu Motoshima, Junji Yatsuda, Taizo Hibi, Tomomi Kamba

Medical Molecular Morphology · 2024-03 · 57 (1) · 68-75

DOI: 10.1007/s00795-023-00374-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Molecular Morphology, online erschienen am 22.11.2023. Verfasst von Toshiki Anami und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Kumamoto Chuo-ku, Kumamoto, 860-8556, Japan. yc…. Hauptthemen laut MEDLINE: Carcinoma, Embryonal, Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science London.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serpinb9 is an inhibitor of granzyme B and is potentially involved in the immune escape of tumor cells. In the present study, bioinformatics analysis using open databases suggested that SerpinB9 is overexpressed in testicular embryonal carcinoma. Immunohistological analysis was performed on 28 cases of testicular germ cell tumors to investigate the relationship between SerpinB9 expression in testicular germ cell tumors and the tumor immune environment. SerpinB9 was significantly upregulated in the non-seminoma group and inversely correlated with the number of tumor-infiltrating CD8-positive cells. In addition, yolk sac tumors were characterized by the loss of human leukocyte antigen-class I expression. These findings suggest that SerpinB9 contributes to the immune escape of testicular germ cell tumors. Targeting therapy for SerpinB9 might therefore be useful in immunotherapy for testicular germ cell tumors resistant to immune checkpoint inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, EmbryonalNeoplasms, Germ Cell and EmbryonalTesticular NeoplasmsHumansMaleBiomarkers, TumorSerpins

Stichwörter der Autor:innen

Embryonal carcinomaHLASeminomaSerpinB9Yolk sac tumor

Substanzen

Biomarkers, TumorSERPINB9 protein, humanSerpins

Autor:innen und Institutionen

  • Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Kumamoto Chuo-ku, Kumamoto, 860-8556, Japan. ycomo@kumamoto-u.ac.jp.
  • Department of Urology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. ycomo@kumamoto-u.ac.jp.
  • Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Kumamoto Chuo-ku, Kumamoto, 860-8556, Japan.
  • Department of Urology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Pediatric Surgery and Transplantation, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Center for Metabolic Regulation of Healthy Aging, Kumamoto University, Kumamoto, Japan.

Förderung

  • Japan Society for the Promotion of Science London

Zitieren

APA

Anami, T., Ibe, Y., Li, L., Komohara, Y., Hirao, H., Harada, M., Yano, H., Fujiwara, Y., Motoshima, T., Yatsuda, J., Hibi, T., & Kamba, T. (2024). Overexpression of SerpinB9 in non-seminomatous germ cell tumors. Medical Molecular Morphology, 57(1), 68-75. https://doi.org/10.1007/s00795-023-00374-9

Vancouver

Anami T, Ibe Y, Li L, Komohara Y, Hirao H, Harada M, et al. Overexpression of SerpinB9 in non-seminomatous germ cell tumors. Medical Molecular Morphology. 2024;57(1):68-75. doi:10.1007/s00795-023-00374-9

BibTeX
@article{Anami2024,
  author = {Anami, Toshiki and Ibe, Yuki and Li, Lianbo and Komohara, Yoshihiro and Hirao, Hiroki and Harada, Mamoru and Yano, Hiromu and Fujiwara, Yukio and Motoshima, Takanobu and Yatsuda, Junji and Hibi, Taizo and Kamba, Tomomi},
  title = {Overexpression of SerpinB9 in non-seminomatous germ cell tumors},
  journal = {Medical Molecular Morphology},
  year = {2024},
  volume = {57},
  number = {1},
  pages = {68--75},
  doi = {10.1007/s00795-023-00374-9}
}
Kostenlos starten →